Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 564 (ZNF564) is a human gene encoding a predicted DNA-binding transcription factor belonging to the zinc finger protein family, characterized by sequence-specific nucleic acid recognition motifs and potential involvement in transcriptional regulation in the nucleus. ZNF564 is annotated to enable RNA polymerase II cis-regulatory region sequence-specific DNA binding. Zinc finger proteins represent a large, structurally diverse class of DNA-binding proteins with roles in gene expression, cell development, and apoptosis. ZNF564 is a protein-coding gene with unclear specific biological pathways and disease roles, and there is currently no evidence connecting it to direct pharmacological targeting or clinical biomarker use.
Not applicable; no known drugs target ZNF564, and its primary function is as a transcription factor
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 564 (ZNF564).